Glioblastoma cancer stem cells: Biomarker and therapeutic advances

Neurochemistry International

Volumn 71, Issue 1, 2014, Pages 1-7

  Pointer, Kelli B ^a,b   Clark, Paul A ^a   Zorniak, Michael ^a,c   Alrfaei, Bahauddeen M ^a,d,e   Kuo, John S ^a,b,c,d,e,f  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Cellular and Molecular Biology   (United States)

^c Neuroscience Training Program   (United States)

^d Cell and Molecular Biology Program   (United States)

^e Human Oncology   (United States)

^f UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Biomarkers; Cancer stem cells; Glioblastoma; Phage antibody display; Yeast antibody display

Indexed keywords

DNA METHYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; LAPATINIB; PROTEIN P53; RETINOBLASTOMA PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; TEMOZOLOMIDE; BIOLOGICAL MARKER;

ANTIBODY LIBRARY; APOPTOSIS; ARTICLE; BIOPANNING; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENICITY; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CLINICAL TRIAL (TOPIC); CYTOLOGY; CYTOTOXICITY; DNA REPLICATION; GENOME ANALYSIS; GLIOBLASTOMA; GLIOBLASTOMA CANCER STEM CELL; HUMAN; METASTASIS; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; QUALITY OF LIFE; SOMATIC MUTATION; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; TUMOR GROWTH; YEAST; ANIMAL; BRAIN NEOPLASMS; DRUG RESISTANCE; GENETICS; HUMAN GENOME; METABOLISM;

ANIMALS; BIOMARKERS; BRAIN NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS;

EID: 84897508762     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.03.005     Document Type: Review

References (108)

1. S. Alcantara Llaguno et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model Cancer Cell 15 1 2009 45 56
2. K.D. Aldape et al. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance J. Neuropathol. Exp. Neurol. 63 7 2004 700 707 (Pubitemid 38891086)
3. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. USA 100 7 2003 3983 3988 (Pubitemid 36418143)
4. A. Ayuso-Sacido et al. Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells J. Neuro-oncol. 97 3 2010 323 337
5. A. Ballantyne, and S. Dhillon Trastuzumab emtansine: first global approval Drugs 73 7 2013 755 765
6. S. Bao et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 7120 2006 756 760 (Pubitemid 44949604)
7. S. Bao et al. Targeting cancer stem cells through L1CAM suppresses glioma growth Cancer Res. 68 15 2008 6043 6048
8. C.F. Barbas 3rd, A.S. Kang, R.A. Lerner, and S.J. Benkovic Assembly of combinatorial antibody libraries on phage surfaces: the gene III site Proc. Natl. Acad. Sci. USA 88 18 1991 7978 7982 (Pubitemid 21915278)
9. C.F. Barbas 3rd, J.D. Bain, D.M. Hoekstra, and R.A. Lerner Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem Proc. Natl. Acad. Sci. USA 89 10 1992 4457 4461
10. S. Beck et al. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells Biomaterials 32 33 2011 8518 8528
11. M. Better, C.P. Chang, R.R. Robinson, and A.H. Horwitz Escherichia coli secretion of an active chimeric antibody fragment Science 240 4855 1988 1041 1043
12. K.P. Bhat et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma Cancer Cell 24 3 2013 331 346
13. A.M. Bleau et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells Cell Stem Cell 4 3 2009 226 235
14. E.T. Boder, K.S. Midelfort, and K.D. Wittrup Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity Proc. Natl. Acad. Sci. USA 97 20 2000 10701 10705
15. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 3 7 1997 730 737 (Pubitemid 27298715)
16. E. Cabib, R. Roberts, and B. Bowers Synthesis of the yeast cell wall and its regulation Annu. Rev. Biochem. 51 1982 763 793
17. P. Carter, and A.M. Merchant Engineering antibodies for imaging and therapy Curr. Opin. Biotechnol. 8 4 1997 449 454 (Pubitemid 27351282)
18. CBTRUS, 2006. Primary Brain Tumors in the United States Statistical Report 1998-2002. Central Brain Tumor Registry of the United States.
19. J. Chen et al. A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 7412 2012 522 526
20. Y.K. Cho, I. Chen, X. Wei, L. Li, and E.V. Shusta A yeast display immunoprecipitation method for efficient isolation and characterization of antigens J. Immunol. Methods 341 1-2 2009 117 126
21. B.D. Choi et al. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma Proc. Natl. Acad. Sci. USA 110 1 2013 270 275
22. T. Clackson, H.R. Hoogenboom, A.D. Griffiths, and G. Winter Making antibody fragments using phage display libraries Nature 352 6336 1991 624 628 (Pubitemid 21912394)
23. P.A. Clark et al. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem - like cell resistance to EGFRTargeted inhibition Neoplasia 14 5 2012 420 428
24. P.A. Clark et al. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition Neoplasia 14 5 2012 420 428
25. V. Clement et al. Marker-independent identification of glioma-initiating cells Nat. Methods 7 3 2010 224 228
26. H.J. de Haard et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies J. Biol. Chem. 274 26 1999 18218 18230
27. T. Denysenko et al. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies Cell Biochem. Funct. 28 5 2010 343 351
28. M. Diehn et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 7239 2009 780 783
29. T. Doucette et al. Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas Cancer Immunol. Res. 1 112 2013
30. J.D. Ebben et al. The cancer stem cell paradigm: a new understanding of tumor development and treatment Expert Opin. Ther. Targets 14 6 2010 621 632
31. J.D. Ebben, M. Zorniak, P.A. Clark, and J.S. Kuo Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine World Neurosurg. 76 3-4 2011 270 275
32. M.J. Feldhaus et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library Nat. Biotechnol. 21 2 2003 163 170 (Pubitemid 36188215)
33. H.A. Fine Glioma stem cells: not all created equal Cancer Cell 15 4 2009 247 249
34. A.M. Friel et al. Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells Reprod. Biol. Endocrinol. 8 2010 147
35. S.A. Gai, and K.D. Wittrup Yeast surface display for protein engineering and characterization Curr. Opin. Struct. Biol. 17 4 2007 467 473 (Pubitemid 47454774)
36. H. Gal et al. A rapid assay for drug sensitivity of glioblastoma stem cells Biochem. Biophys. Res. Commun. 358 3 2007 908 913 (Pubitemid 46802474)
37. J. Glanville et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire Proc. Natl. Acad. Sci. USA 106 48 2009 20216 20221
38. M. Greaves, and C.C. Maley Clonal evolution in cancer Nature 481 7381 2012 306 313
39. S.A. Grupp et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia N. Engl. J. Med. 368 16 2013 1509 1518
40. H.S. Gunther et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria Oncogene 27 20 2008 2897 2909 (Pubitemid 351620450)
41. D. Guo et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway Cancer Discov. 1 5 2011 442 456
42. A. Gurney et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors Proc. Natl. Acad. Sci. USA 109 29 2012 11717 11722
43. P.M. Harari, G.W. Allen, and J.A. Bonner Biology of interactions: antiepidermal growth factor receptor agents J. Clin. Oncol. 25 26 2007 4057 4065 (Pubitemid 47492950)
44. M.E. Hegi et al. MGMT gene silencing and benefit from temozolomide in glioblastoma N. Engl. J. Med. 352 10 2005 997 1003 (Pubitemid 40349502)
45. L.J. Holt, C. Enever, R.M. de Wildt, and I.M. Tomlinson The use of recombinant antibodies in proteomics Curr. Opin. Biotechnol. 11 5 2000 445 449
46. H.R. Hoogenboom Designing and optimizing library selection strategies for generating high-affinity antibodies Trends Biotechnol. 15 2 1997 62 70 (Pubitemid 27099628)
47. M.A. Huie et al. Antibodies to human fetal erythroid cells from a nonimmune phage antibody library Proc. Natl. Acad. Sci. USA 98 5 2001 2682 2687 (Pubitemid 32209542)
48. T.N. Ignatova et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro Glia 39 3 2002 193 206
49. S. Jaiswal et al. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias Proc. Natl. Acad. Sci. USA 100 17 2003 10002 10007 (Pubitemid 37087058)
50. L. Jin, K.J. Hope, Q. Zhai, F. Smadja-Joffe, and J.E. Dick Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nat. Med. 12 10 2006 1167 1174 (Pubitemid 44527352)
51. J.J. Kelly et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens Stem Cells 27 8 2009 1722 1733
52. A. Knappik et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides J. Mol. Biol. 296 1 2000 57 86
53. R. Kollar et al. Architecture of the yeast cell wall. Beta(1->6)-glucan interconnects mannoprotein, beta(1->)3-glucan, and chitin J. Biol. Chem. 272 28 1997 17762 17775 (Pubitemid 27311216)
54. H. Korkaya, A. Paulson, F. Iovino, and M.S. Wicha HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion Oncogene 27 47 2008 6120 6130
55. T. Kretzschmar, and T. von Ruden Antibody discovery: phage display Curr. Opin. Biotechnol. 13 6 2002 598 602 (Pubitemid 35448062)
56. A.V. Krivtsov et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9 Nature 442 7104 2006 818 822 (Pubitemid 44258912)
57. A.B. Lassman et al. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 Clin. Cancer Res. 11 21 2005 7841 7850 (Pubitemid 41611629)
58. J. Lee et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines Cancer Cell 9 5 2006 391 403 (Pubitemid 43668737)
59. F. Li, B. Tiede, J. Massague, and Y. Kang Beyond tumorigenesis: cancer stem cells in metastasis Cell Res. 17 1 2007 3 14 (Pubitemid 46096419)
60. B. Liu, and J.D. Marks Applying phage antibodies to proteomics: selecting single chain Fv antibodies to antigens blotted on nitrocellulose Anal. Biochem. 286 1 2000 119 128
61. H. Liu, C.A. Styles, and G.R. Fink Saccharomyces cerevisiae S288C has a mutation in FLO8, a gene required for filamentous growth Genetics 144 3 1996 967 978 (Pubitemid 26378242)
62. G. Liu et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Mol. Cancer 5 2006 67
63. Q. Liu et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors J. Neuro-oncol. 94 1 2009 1 19
64. Y. Liu, Q. Gu, J.P. Hou, J. Han, and J. Ma A network-assisted co-clustering algorithm to discover cancer subtypes based on gene expression BMC Bioinformatics 15 1 2014 37
65. D. Louis, H. Ohgaki, O. Wiestler, and W. Cavenee WHO Classification of Tumours of the Central Nervous System 2007 IARC Lyon
66. W.A. Marasco, and J. Sui The growth and potential of human antiviral monoclonal antibody therapeutics Nat. Biotechnol. 25 12 2007 1421 1434 (Pubitemid 350233138)
67. J.D. Marks et al. By-passing immunization. Human antibodies from V-gene libraries displayed on phage J. Mol. Biol. 222 3 1991 581 597
68. J. McCafferty, A.D. Griffiths, G. Winter, and D.J. Chiswell Phage antibodies: filamentous phage displaying antibody variable domains Nature 348 6301 1990 552 554 (Pubitemid 120015109)
69. C.E. Meacham, and S.J. Morrison Tumour heterogeneity and cancer cell plasticity Nature 501 7467 2013 328 337
70. J.R. Molina, Y. Hayashi, C. Stephens, and M.M. Georgescu Invasive glioblastoma cells acquire stemness and increased Akt activation Neoplasia 12 6 2010 453 463
71. R.A. Morgan et al. Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma Hum. Gene Ther. 23 10 2012 1043 1053
72. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 7123 2007 106 110 (Pubitemid 46067310)
73. W.M. Pardridge, and R.J. Boado Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier Methods Enzymol. 503 2012 269 292
74. D.W. Parsons et al. An integrated genomic analysis of human glioblastoma multiforme Science 321 5897 2008 1807 1812
75. L.R. Pepper, Y.K. Cho, E.T. Boder, and E.V. Shusta A decade of yeast surface display technology: where are we now? Comb. Chem. High Throughput Screen. 11 2 2008 127 134 (Pubitemid 351347217)
76. A.S. Perelson Immune network theory Immunol. Rev. 110 1989 5 36 (Pubitemid 19216007)
77. M. Perez-Caro et al. Cancer induction by restriction of oncogene expression to the stem cell compartment EMBO J. 28 1 2009 8 20
78. Piccirillo, S.G., Vescovi, A.L., 2006. Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells. Ernst Schering Foundation symposium proceedings (5):59-81.
79. S.M. Pollard et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens Cell Stem Cell 4 6 2009 568 580
80. B. Pro et al. Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study J. Clin. Oncol. 30 18 2012 2190 2196
81. T.A. Read, B. Hegedus, R. Wechsler-Reya, and D.H. Gutmann The neurobiology of neurooncology Ann. Neurol. 60 1 2006 3 11
82. R.C. Roovers et al. Evidence for a bias toward intracellular antigens in the local humoral anti-tumor immune response of a colorectal cancer patient revealed by phage display Int. J. Cancer 93 6 2001 832 840 (Pubitemid 32756753)
83. S. Pal et al. Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes Nucleic Acids Res. 2014 http://nar.oxfordjournals.org/content/early/2014/02/06/nar.gku121.long
84. C.M.E. Sauvageot et al. Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells Neuro-oncology 11 2 2008 109 121
85. D. Sciuscio et al. Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres Clin. Cancer Res. 17 2 2011 255 266
86. M. Shackleton, E. Quintana, E.R. Fearon, and S.J. Morrison Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 5 2009 822 829
87. A. Shiras et al. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma Stem Cells 25 6 2007 1478 1489 (Pubitemid 47106016)
88. E.V. Shusta, P.D. Holler, M.C. Kieke, D.M. Kranz, and K.D. Wittrup Directed evolution of a stable scaffold for T-cell receptor engineering Nat. Biotechnol. 18 7 2000 754 759 (Pubitemid 30460692)
89. S.K. Singh et al. Identification of human brain tumour initiating cells Nature 432 7015 2004 396 401 (Pubitemid 39551674)
90. S.K. Singh, I.D. Clarke, T. Hide, and P.B. Dirks Cancer stem cells in nervous system tumors Oncogene 23 43 2004 7267 7273 (Pubitemid 39382160)
91. A. Skerra, and A. Pluckthun Assembly of a functional immunoglobulin Fv fragment in Escherichia coli Science 240 4855 1988 1038 1041
92. G.P. Smith Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 4705 1985 1315 1317 (Pubitemid 15000355)
93. M. Snuderl et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma Cancer Cell 20 6 2011 810 817
94. M.J. Son, K. Woolard, D.-H. Nam, J. Lee, and H.A. Fine SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma Cell Stem Cell 4 5 2009 440 452
95. J.M. Stommel et al. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies Science 318 5848 2007 287 290 (Pubitemid 47574858)
96. R. Stupp et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 10 2005 987 996 (Pubitemid 40349501)
97. TCGA Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 7216 2008 1061 1068
98. B. Thiessen et al. A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation Cancer Chemother. Pharmacol. 65 2 2010 353 361
99. V. Puri, E. Streaker, P. Prabakaran, Z. Zhu, and D.S. Dimitrov Highly efficient selection of epitope specific antibody through competitive yeast display library sorting mAbs 5 4 2013 533 539
100. E.G. Van Meir et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma CA Cancer J. Clin. 60 3 2010 166 193
101. I. Vivanco, and I.K. Mellinghoff Epidermal growth factor receptor inhibitors in oncology Curr. Opin. Oncol. 22 6 2010 573 578
102. I. Vivanco et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors Cancer Discov. 2 5 2012 458 471
103. H. Wakimoto et al. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells Neuro. Oncol. 14 2 2012 132 144
104. X.X. Wang, Y.K. Cho, and E.V. Shusta Mining a yeast library for brain endothelial cell-binding antibodies Nat. Methods 4 2 2007 143 145 (Pubitemid 46454683)
105. J. Zhang, M.F. Stevens, and T.D. Bradshaw Temozolomide: mechanisms of action, repair and resistance Curr. Mol. Pharmacol. 5 1 2012 102 114
106. H. Zhou, Y.L. Zhang, G. Lu, H. Ji, and C.P. Rodi Recombinant antibody libraries and selection technologies New Biotechnol. 28 5 2011 448 452
107. X. Zhu et al. Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells Mol. Cancer Ther. 9 7 2010 2131 2141
108. M. Zorniak et al. Differential expression of 2′,3′-cyclic- nucleotide 3′-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival Clin. Cancer Res. 18 13 2012 3628 3636